首页> 外文OA文献 >First Experimental Demonstration of the Multipotential Carcinogenic Effects of Aspartame Administered in the Feed to Sprague-Dawley Rats
【2h】

First Experimental Demonstration of the Multipotential Carcinogenic Effects of Aspartame Administered in the Feed to Sprague-Dawley Rats

机译:首次实验证明了饲料中阿斯巴甜对Sprague-Dawley大鼠的多潜能致癌作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The Cesare Maltoni Cancer Research Center of the European Ramazzini Foundation has conducted a long-term bioassay on aspartame (APM), a widely used artificial sweetener. APM was administered with feed to 8-week-old Sprague-Dawley rats (100–150/sex/group), at concentrations of 100,000, 50,000, 10,000, 2,000, 400, 80, or 0 ppm. The treatment lasted until natural death, at which time all deceased animals underwent complete necropsy. Histopathologic evaluation of all pathologic lesions and of all organs and tissues collected was routinely performed on each animal of all experimental groups. The results of the study show for the first time that APM, in our experimental conditions, causes a) an increased incidence of malignant-tumor–bearing animals with a positive significant trend in males (p ≤ 0.05) and in females (p ≤ 0.01), in particular those females treated at 50,000 ppm (p ≤ 0.01); b) an increase in lymphomas and leukemias with a positive significant trend in both males (p ≤ 0.05) and females (p ≤ 0.01), in particular in females treated at doses of 100,000 (p ≤ 0.01), 50,000 (p ≤ 0.01), 10,000 (p ≤ 0.05), 2,000 (p ≤ 0.05), or 400 ppm (p ≤ 0.01); c) a statistically significant increased incidence, with a positive significant trend (p ≤ 0.01), of transitional cell carcinomas of the renal pelvis and ureter and their precursors (dysplasias) in females treated at 100,000 (p ≤ 0.01), 50,000 (p ≤ 0.01), 10,000 (p ≤ 0.01), 2,000 (p ≤ 0.05), or 400 ppm (p ≤ 0.05); and d) an increased incidence of malignant schwannomas of peripheral nerves with a positive trend (p ≤ 0.05) in males. The results of this mega-experiment indicate that APM is a multipotential carcinogenic agent, even at a daily dose of 20 mg/kg body weight, much less than the current acceptable daily intake. On the basis of these results, a reevaluation of the present guidelines on the use and consumption of APM is urgent and cannot be delayed.
机译:欧洲Ramazzini基金会的Cesare Maltoni癌症研究中心已经对广泛使用的人造甜味剂阿斯巴甜(APM)进行了长期生物测定。向8周大的Sprague-Dawley大鼠(100-150 /性别/组)饲喂APM,其浓度为100,000、50,000、10,000、2,000、400、80或0 ppm。治疗一直持续到自然死亡,这时所有死者的动物都进行了完整的尸检。通常在所有实验组的每只动物上进行所有病理性病变以及收集的所有器官和组织的组织病理学评估。研究结果首次表明,在我们的实验条件下,APM导致:a)荷瘤动物的发病率增加,雄性(p≤0.05)和雌性(p≤0.01)呈显着正趋势。 ),尤其是那些以50,000 ppm处理的女性(p≤0.01); b)男性(p≤0.05)和女性(p≤0.01)的淋巴瘤和白血病均呈显着正趋势,特别是在以100,000(p≤0.01),50,000(50,000 p = 0.01)的剂量治疗的女性中,10,000(p≤0.05),2,000(p≤0.05)或400 ppm(p≤0.01); c)在接受100,000(p≤0.01),50,000(p≤)治疗的女性中,肾盂和输尿管的移行细胞癌及其前体(异型增生)的发生率具有统计学显着性增加,并具有正显着趋势(p≤0.01)。 0.01),10,000(p≤0.01),2,000(p≤0.05)或400 ppm(p≤0.05); d)男性周围神经恶性神经鞘瘤的发生率呈上升趋势(p≤0.05)。这项大型实验的结果表明,即使每天剂量为20 mg / kg体重,APM还是一种潜在的致癌剂,远低于目前可接受的每日摄入量。根据这些结果,对APM的使用和消耗的现行准则进行重新评估是紧迫的,不能延误。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号